Cargando…
Predicting ligand-dependent tumors from multi-dimensional signaling features
Targeted therapies have shown significant patient benefit in about 5–10% of solid tumors that are addicted to a single oncogene. Here, we explore the idea of ligand addiction as a driver of tumor growth. High ligand levels in tumors have been shown to be associated with impaired patient survival, bu...
Autores principales: | Hass, Helge, Masson, Kristina, Wohlgemuth, Sibylle, Paragas, Violette, Allen, John E., Sevecka, Mark, Pace, Emily, Timmer, Jens, Stelling, Joerg, MacBeath, Gavin, Schoeberl, Birgit, Raue, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607260/ https://www.ncbi.nlm.nih.gov/pubmed/28944080 http://dx.doi.org/10.1038/s41540-017-0030-3 |
Ejemplares similares
-
Estimation of immune cell content in tumour tissue using single-cell RNA-seq data
por: Schelker, Max, et al.
Publicado: (2017) -
High- and Low-Affinity Epidermal Growth Factor Receptor-Ligand Interactions Activate Distinct Signaling Pathways
por: Krall, Jordan A., et al.
Publicado: (2011) -
Chemical genomics: what will it take and who gets to play?
por: MacBeath, Gavin
Publicado: (2001) -
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)
por: Schoeberl, Birgit, et al.
Publicado: (2017) -
Linear combinations of docking affinities explain quantitative differences in RTK signaling
por: Gordus, Andrew, et al.
Publicado: (2009)